Guinea-Bissau vs Myanmar: Proportion of the target population who received a 3rd dose of
Guinea-Bissau
74.0%
in 2024
Myanmar
71.0%
in 2024
Guinea-Bissau rank
127th
Myanmar rank
131st
Proportion of the target population who received a 3rd dose of over time
- Guinea-Bissau
- Myanmar
How they compare
Guinea-Bissau currently reports 74.0% against 71.0% in Myanmar, a difference of 3.0%.
The two have swapped places 2 times across 9 shared years of data; in 2016 it was Guinea-Bissau ahead.
Guinea-Bissau ranks 127th and Myanmar ranks 131st of 157 countries.
Guinea-Bissau has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 80.5% | 71.0% | 9.5% | Guinea-Bissau |
| 2020s | 72.6% | 63.6% | 9.0% | Guinea-Bissau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Guinea-Bissau or Myanmar?
- Guinea-Bissau, at 74.0% against 71.0% in Myanmar as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Guinea-Bissau and Myanmar?
- 3.0%, with Guinea-Bissau ahead.
- How many years of comparable data are there for Guinea-Bissau and Myanmar?
- 9 years are reported by both, from 2016 to 2024.
- How do Guinea-Bissau and Myanmar rank globally for proportion of the target population who received a 3rd dose of?
- Guinea-Bissau ranks 127th and Myanmar ranks 131st of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.